96 related articles for article (PubMed ID: 18257543)
1. Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.
Hoffman A; Qadri B; Frant J; Katz Y; Bhusare SR; Breuer E; Hadar R; Reich R
J Med Chem; 2008 Mar; 51(5):1406-14. PubMed ID: 18257543
[TBL] [Abstract][Full Text] [Related]
2. Orally active, antimetastatic, nontoxic diphenyl ether-derived carbamoylphosphonate matrix metalloproteinase inhibitors.
Frant J; Veerendhar A; Chernilovsky T; Nedvetzki S; Vaksman O; Hoffman A; Breuer E; Reich R
ChemMedChem; 2011 Aug; 6(8):1471-7. PubMed ID: 21656908
[TBL] [Abstract][Full Text] [Related]
3. Carbamoylphosphonates inhibit autotaxin and metastasis formation in vivo.
Reich R; Hoffman A; Suresh RR; Shai O; Frant J; Maresca A; Supuran CT; Breuer E
J Enzyme Inhib Med Chem; 2015; 30(5):767-72. PubMed ID: 25669348
[TBL] [Abstract][Full Text] [Related]
4. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studies.
Li L; Zhu Z; Joshi B; Zhang C; Johnson CR; Marnett LJ; Honn KV; Crissman JD; Porter AT; Tang DG
Anticancer Res; 1999; 19(1A):61-9. PubMed ID: 10226525
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.
Le Diguarher T; Chollet AM; Bertrand M; Hennig P; Raimbaud E; Sabatini M; Guilbaud N; Pierré A; Tucker GC; Casara P
J Med Chem; 2003 Aug; 46(18):3840-52. PubMed ID: 12930146
[TBL] [Abstract][Full Text] [Related]
6. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration.
Wakabayashi C; Hasegawa H; Murata J; Saiki I
Oncol Res; 1997; 9(8):411-7. PubMed ID: 9436194
[TBL] [Abstract][Full Text] [Related]
7. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
8. Carbamoylphosphonate matrix metalloproteinase inhibitors 3: in vivo evaluation of cyclopentylcarbamoylphosphonic acid in experimental metastasis and angiogenesis.
Reich R; Katz Y; Hadar R; Breuer E
Clin Cancer Res; 2005 May; 11(10):3925-9. PubMed ID: 15897594
[TBL] [Abstract][Full Text] [Related]
9. Antimetastatic activity of pinosylvin, a natural stilbenoid, is associated with the suppression of matrix metalloproteinases.
Park EJ; Park HJ; Chung HJ; Shin Y; Min HY; Hong JY; Kang YJ; Ahn YH; Pyee JH; Lee SK
J Nutr Biochem; 2012 Aug; 23(8):946-52. PubMed ID: 21937212
[TBL] [Abstract][Full Text] [Related]
10. Antimetastatic potential of vernolide-A, a sesquiterpenoid from Vernonia cinerea L.
Pratheeshkumar P; Kuttan G
Hum Exp Toxicol; 2012 Jan; 31(1):66-80. PubMed ID: 21708884
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the application of MMP-9 inhibitor in skin melanoma: experimental study.
Aksenenko MB; Ruksha TG
Bull Exp Biol Med; 2013 Mar; 154(5):594-6. PubMed ID: 23658876
[TBL] [Abstract][Full Text] [Related]
12. Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities.
Ji MK; Shi Y; Xu JW; Lin X; Lin JY
Anticancer Drugs; 2013 Jun; 24(5):461-72. PubMed ID: 23442578
[TBL] [Abstract][Full Text] [Related]
13. Chemoinhibitory effect of mulberry anthocyanins on melanoma metastasis involved in the Ras/PI3K pathway.
Huang HP; Shih YW; Chang YC; Hung CN; Wang CJ
J Agric Food Chem; 2008 Oct; 56(19):9286-93. PubMed ID: 18767864
[TBL] [Abstract][Full Text] [Related]
14. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
Lee DY; Park K; Kim SK; Park RW; Kwon IC; Kim SY; Byun Y
Clin Cancer Res; 2008 May; 14(9):2841-9. PubMed ID: 18451252
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.
Kimura Y; Aoki J; Kohno M; Ooka H; Tsuruo T; Nakanishi O
Cancer Chemother Pharmacol; 2002 Apr; 49(4):322-8. PubMed ID: 11914912
[TBL] [Abstract][Full Text] [Related]
16. [Experimental antimetastatic activity of aclarubicin].
Viadro MM; Terent'eva TG
Antibiot Khimioter; 1988 Nov; 33(11):845-8. PubMed ID: 3228327
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
[TBL] [Abstract][Full Text] [Related]
19. Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.
Song J; Peng P; Chang J; Liu MM; Yu JM; Zhou L; Sun X
Bioorg Med Chem Lett; 2016 May; 26(9):2174-8. PubMed ID: 27038494
[TBL] [Abstract][Full Text] [Related]
20. Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B16F-10 melanoma cells.
Hamsa TP; Kuttan G
Phytother Res; 2012 Apr; 26(4):568-78. PubMed ID: 21953764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
